Immuno-positron emission tomography (immunoPET) is a paradigm-shifting molecular
imaging modality combining the superior targeting specificity of monoclonal antibody (mAb) …

Abstract Positron Emission Tomography (PET) experienced accelerated development and
has become an established method for medical research and clinical routine diagnostics on …

Pretargeting is a multi-step process that first has an unlabeled bispecific antibody (bsMAb)
localize within a tumor by virtue of its anti-tumor binding site (s) before administering a small …

Selective delivery of radionuclides to tumors may be accomplished using a two-step
approach, in which in the first step the tumor is pretargeted with an unlabeled antibody …

During the last decade, the utilization of 68Ga for the development of imaging agents has
increased considerably with the leading position in the oncology. The imaging of infection …

The prognosis of medullary thyroid carcinoma (MTC) varies from long-to short-term survival
based on such prognostic factors as serum calcitonin and carcinoembryonic antigen (CEA) …

Introduction This pilot study evaluated the imaging performance of pretargeted
immunological positron emission tomography (immuno-PET) using an anti …

Bispecific antibody pretargeting is a two-step procedure for selectively delivering
radionuclides to tumors. The procedure was developed to solve a number of problems …

Advances in recombinant protein technology have facilitated the production of increasingly
complex fusion proteins with multivalent, multifunctional designs for use in various in vitro …

During the past two decades, considerable research has been devoted to radionuclide
therapy using radiolabeled monoclonal antibodies and receptor binding agents …